rediff.com
e.g. Tata motors, Reliance MF, 500570
BSE | NSE

GlaxoSmithKline Pharmaceuticals Ltd.

500660 GLAXO Group (A)

01 Oct,15:29
2727.10
-27.70 (-1.01%)
HOW HOT IS THIS STOCK?

Last 15 days data © Rediff.com

Add to Watchlist
 
Day
Wk
Mn
6Mn
Yr
Volume Prev close Day's H/L (Rs.) 52wk H/L (Rs.) Mkt Cap (Rs. Cr)

GlaxoSmithKline Pharmaceuticals Ltd.

BUYSELL

4,604 2,754.80 2,754.80 - 2,709.00 3,087.95 - 1,387.90 46,197.08
NSE | BSE

GlaxoSmithKline Pharmaceuticals Ltd.

GLAXO

01 Oct,15:52
2735.35
-15.20 (-0.55%)
HOW HOT IS THIS STOCK?

Last 15 days data © Rediff.com

Add to Watchlist
 
Day
Wk
Mn
6Mn
Yr
Volume Prev close Day's H/L (Rs.) 52wk H/L (Rs.) Turnover (Rs. Lacs)

GlaxoSmithKline Pharmaceuticals Ltd.

BUYSELL

42,937 2750.55 2,763.00 - 2,712.05 3,088.00 - 1,385.05 1,172.01
(Rs. Crore)

Financial Results of GlaxoSmithKline Pharmaceuticals Ltd.

Mar ' 24Mar ' 23Mar ' 22Mar ' 21Mar ' 20
Sales3,407.253,216.343,217.513,193.733,224.68
Operating profit900.65799.41755.83694.95658.45
Interest1.801.811.993.536.34
Gross profit1,022.33899.12830.06801.61729.67
EPS (Rs)34.5135.8799.7921.116.50

See more in Research Center »

About GlaxoSmithKline Pharmaceuticals Ltd.

GlaxoSmithKline Pharmaceuticals Ltd is an Indian research-based pharmaceutical and healthcare company, and a subsidiary of GSK. The company's product portfolio includes prescription medicines and vaccines. Its prescription medicines range across therapeutic areas such as anti-infectives, dermatology, gynaecology, diabetes, oncology, cardiovascular disease, and respiratory diseases. It also offers a range of vaccines, for the prevention of hepatitis A, hepatitis B, invasive disease caused by H, influenzae, chickenpox, diphtheria, pertussis, tetanus, rotavirus, cervical cancer, and others. Wikipedia

News for Pharmaceuticals and health care

Real Estate...
Real Estate Investment Soars 45% in Q3 2024: Colliers
Institutional investments in Indian real estate surged to USD 1.15 billion in July-September, driven by strong demand for premium homes and offices. Colliers reports office segment attracting USD...
Oct 02, 2024 11:02
India's Potential...
India's Potential as Green Shipbuilding Hub: Maritime Expert
India's government focus on alternative fuels and renewable energy positions it as a potential hub for green shipbuilding, according to maritime expert Cristina Saenz de Santa Maria of DNV.
Oct 02, 2024 10:45
UP Govt....
UP Govt. Announces Cinema Hall Scheme: Incentives & Industry Status for IT
Uttar Pradesh government approves a scheme to revive cinema halls, upgrade existing ones, and provide incentives. IT/ITES sector also gets industry status.
Oct 01, 2024 22:23
Plutus Wealth...
Plutus Wealth Buys SpiceJet Shares for Rs 50 Crore
Plutus Wealth Management has acquired a 0.58% stake in SpiceJet for Rs 50 crore through an open market transaction. The shares were bought at an average price of Rs 66.70 apiece.
Oct 01, 2024 22:13
Odisha to Host...
Odisha to Host Ambassadors' Meet Ahead of Biz Summit
Odisha government to host a meeting of ambassadors in Delhi to showcase its industrial ecosystem and investment opportunities ahead of the Utkarsh Odisha: Make in Odisha Conclave 2025.
Oct 01, 2024 22:04

More News »

Top News

Real Estate...
Real Estate Investment Soars 45% in Q3 2024: Colliers
Institutional investments in Indian real estate surged to USD 1.15 billion in July-September, driven by strong demand for premium homes and offices. Colliers reports office segment attracting USD...
Oct 02, 2024 11:02
India's Potential...
India's Potential as Green Shipbuilding Hub: Maritime Expert
India's government focus on alternative fuels and renewable energy positions it as a potential hub for green shipbuilding, according to maritime expert Cristina Saenz de Santa Maria of DNV.
Oct 02, 2024 10:45
Mahatma Gandhi Jayanti: Markets Closed
Indian stock, currency, and commodities markets will be closed on Wednesday, October 2nd, in observance of Mahatma Gandhi Jayanti.
Oct 02, 2024 09:48
EU Deforestation Regulation: Concerns and Support
The EU's Deforestation Regulation sparks debate, with countries, businesses, and environmental groups expressing concerns and support. Learn about the EUDR's impact on trade and forest conservation.
Oct 02, 2024 09:02
UP Cabinet Approves Self-Employment Scheme for Youths && Private Universities
Uttar Pradesh cabinet approves a self-employment scheme for youths with loan subsidies for microenterprises && service sector projects. Two new private universities in Mathura &&...
Oct 01, 2024 22:49

More Top News »

Report Card

PE Ratios
79.02
EPS (Rs.)
34.51
Sales (Rs. Cr)
811.00
Face Value (Rs.)
10
Net Profit Margin (%)
17.16
Last Bonus
1:1
Last Dividend(%)
320
Return on Average Equity
32.6

Compare 'GlaxoSmithKline Pharmaceuticals Ltd.' with other stocks

  • Sun Pharmaceutical Industries Ltd.
  • 1,926.30
  • Compare
  • Dr. Reddy's Laboratories Ltd.
  • 6,757.90
  • Compare
  • Zydus Lifesciences Ltd.
  • 1,068.35
  • Compare
  • Apollo Hospitals Enterprise Ltd.
  • 7,195.75
  • Compare
  • Max Healthcare Institute Ltd.
  • 985.45
  • Compare
  • Alkem Laboratories Ltd.
  • 6,060.90
  • Compare
  • Divi's Laboratories Ltd.
  • 5,446.20
  • Compare

Most Active

  • Change (Rs.)
  •  

GlaxoSmithKline Pharmaceuticals Ltd. performance snapshot

If you had invested Rs.  in GlaxoSmithKline Pharmaceuticals Ltd.,     ago

You would have  Rs. 000.00 

Add to Portfolio

Peers

  • LTP
  • Change (Rs.)
  • Change %
  • Mkt Cap (Rs. Cr)
  • Volume
Close
Add GlaxoSmithKline Pharmaceuticals Ltd. to your Portfolio
 
 
BSE NSE  
 
Close
Add GlaxoSmithKline Pharmaceuticals Ltd. to your Watchlist
Alert me if price...
*Watchlist will be based on BSE values
Close